Akoya Biosciences, Inc.

Akoya Biosciences, Inc. (AKYA) priced its initial public offering on Apr 19, 2021 at $20.00 per share, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $713.8M. J.P. Morgan was lead-left underwriter, joined by Morgan Stanley, Piper Sandler and Canaccord Genuity. DLA Piper advised the company and Davis Polk advised the underwriters.

Akoya Biosciences, Inc. is a life sciences technology company offering spatial biology tools for research. Its CODEX and Phenoptics platforms, with reagents, software and services, let scientists analyze tissue and map cells and proteins from discovery through translational and clinical research.

Status

IPO

Ticker

AKYA

Exchange

Nasdaq Global Select

Priced

Apr 19, 2021

IPO price

$20.00

Market cap at IPO price

$713.8M

First filed

Mar 26, 2021

Underwriters

J.P. Morgan, Morgan Stanley, Piper Sandler and Canaccord Genuity

Company counsel

DLA Piper

Underwriters' counsel

Davis Polk

Sector

Industrials & materials

Country / state

MA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.